Sarah J. Salino-Kamli
Aberdeen, SCT AB243FX, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Deletion of PTP1B in cardiomyocytes alters cardiac metabolic signaling to protect against cardiomyopathy induced by a high-fat diet.
Journal: Science signaling
Published: July 22, 2025
Myeloid PTP1B deficiency protects against atherosclerosis by improving cholesterol homeostasis through an AMPK-dependent mechanism.
Journal: Journal of translational medicine
Published: April 12, 2023
Induction of experimental diabetes and diabetic nephropathy using anomer-equilibrated streptozotocin in male C57Bl/6J mice.
Journal: Biochemical and biophysical research communications
Published: January 10, 2023
Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice.
Journal: Scientific reports
Published: October 19, 2022
The BACE1 inhibitor LY2886721 improves diabetic phenotypes of BACE1 knock-in mice.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: January 20, 2021
NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia.
Journal: Neuropharmacology
Published: April 15, 2020
Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice.
Journal: Biochemical pharmacology
Published: March 25, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026